Raymond James Financial Inc. Invests $807,000 in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Raymond James Financial Inc. purchased a new position in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 77,314 shares of the company's stock, valued at approximately $807,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Barclays PLC raised its position in Integral Ad Science by 207.1% during the 3rd quarter. Barclays PLC now owns 127,733 shares of the company's stock worth $1,380,000 after buying an additional 86,133 shares during the last quarter. Franklin Resources Inc. raised its position in Integral Ad Science by 12.9% in the third quarter. Franklin Resources Inc. now owns 110,449 shares of the company's stock valued at $1,191,000 after purchasing an additional 12,647 shares during the period. JPMorgan Chase & Co. grew its stake in shares of Integral Ad Science by 47.6% in the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company's stock worth $7,756,000 after acquiring an additional 231,271 shares in the last quarter. Jennison Associates LLC boosted its stake in shares of Integral Ad Science by 3.3% in the 4th quarter. Jennison Associates LLC now owns 63,538 shares of the company's stock valued at $663,000 after buying an additional 2,046 shares during the period. Finally, Stoneridge Investment Partners LLC increased its position in Integral Ad Science by 139.7% during the fourth quarter. Stoneridge Investment Partners LLC now owns 27,808 shares of the company's stock worth $290,000 after buying an additional 16,208 shares during the period. Hedge funds and other institutional investors own 95.78% of the company's stock.

Insider Transactions at Integral Ad Science

In other news, CEO Lisa Utzschneider sold 8,367 shares of the stock in a transaction that occurred on Wednesday, May 7th. The shares were sold at an average price of $7.37, for a total transaction of $61,664.79. Following the completion of the transaction, the chief executive officer now directly owns 349,574 shares of the company's stock, valued at $2,576,360.38. This represents a 2.34 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold a total of 86,222 shares of company stock valued at $636,252 over the last ninety days. 2.00% of the stock is currently owned by insiders.

Integral Ad Science Stock Performance

Shares of NASDAQ IAS traded down $0.07 during trading hours on Friday, reaching $7.72. 1,389,653 shares of the stock were exchanged, compared to its average volume of 1,035,584. Integral Ad Science Holding Corp. has a 52 week low of $6.26 and a 52 week high of $13.62. The company has a debt-to-equity ratio of 0.07, a quick ratio of 3.71 and a current ratio of 3.71. The firm has a market capitalization of $1.26 billion, a price-to-earnings ratio of 38.60, a P/E/G ratio of 1.06 and a beta of 1.55. The stock's fifty day simple moving average is $7.86 and its 200 day simple moving average is $9.75.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last posted its quarterly earnings data on Friday, February 28th. The company reported $0.09 earnings per share for the quarter, missing analysts' consensus estimates of $0.12 by ($0.03). The company had revenue of $153.00 million during the quarter, compared to analyst estimates of $148.83 million. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The business's revenue for the quarter was up 13.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.06 earnings per share. Sell-side analysts predict that Integral Ad Science Holding Corp. will post 0.26 EPS for the current year.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. Morgan Stanley dropped their price objective on Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Baird R W cut Integral Ad Science from a "strong-buy" rating to a "hold" rating in a report on Friday, March 28th. Stifel Nicolaus lowered their price objective on Integral Ad Science from $15.00 to $13.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Raymond James cut their target price on shares of Integral Ad Science from $16.00 to $11.00 and set an "outperform" rating on the stock in a research note on Monday. Finally, Robert W. Baird reaffirmed a "neutral" rating and set a $9.00 target price (down from $16.00) on shares of Integral Ad Science in a report on Friday, March 28th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $13.15.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.